257 related articles for article (PubMed ID: 21884696)
21. Expression of adenomatous polyposis coli (APC) in tumorigenesis of human oral squamous cell carcinoma.
Tsuchiya R; Yamamoto G; Nagoshi Y; Aida T; Irie T; Tachikawa T
Oral Oncol; 2004 Oct; 40(9):932-40. PubMed ID: 15380172
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
[TBL] [Abstract][Full Text] [Related]
23. The role of Pygo2 for Wnt/ß-catenin signaling activity during intestinal tumor initiation and progression.
Talla SB; Brembeck FH
Oncotarget; 2016 Dec; 7(49):80612-80632. PubMed ID: 27811361
[TBL] [Abstract][Full Text] [Related]
24. Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling.
Kielman MF; Rindapää M; Gaspar C; van Poppel N; Breukel C; van Leeuwen S; Taketo MM; Roberts S; Smits R; Fodde R
Nat Genet; 2002 Dec; 32(4):594-605. PubMed ID: 12426568
[TBL] [Abstract][Full Text] [Related]
25. Wnt signalling pathway in the serrated neoplastic pathway of the colorectum: possible roles and epigenetic regulatory mechanisms.
Fu X; Li L; Peng Y
J Clin Pathol; 2012 Aug; 65(8):675-9. PubMed ID: 22412046
[TBL] [Abstract][Full Text] [Related]
26. Olfactomedin 4 deletion induces colon adenocarcinoma in Apc
Liu W; Li H; Hong SH; Piszczek GP; Chen W; Rodgers GP
Oncogene; 2016 Oct; 35(40):5237-5247. PubMed ID: 26973250
[TBL] [Abstract][Full Text] [Related]
27. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.
Takahashi M; Nakamura Y; Obama K; Furukawa Y
Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202
[TBL] [Abstract][Full Text] [Related]
28. The Wnt connection to tumorigenesis.
Behrens J; Lustig B
Int J Dev Biol; 2004; 48(5-6):477-87. PubMed ID: 15349822
[TBL] [Abstract][Full Text] [Related]
29. Apc bridges Wnt/β-catenin and BMP signaling during osteoblast differentiation of KS483 cells.
Miclea RL; van der Horst G; Robanus-Maandag EC; Löwik CW; Oostdijk W; Wit JM; Karperien M
Exp Cell Res; 2011 Jun; 317(10):1411-21. PubMed ID: 21402068
[TBL] [Abstract][Full Text] [Related]
30. A kinetic model to study the regulation of β-catenin, APC, and Axin in the human colonic crypt.
Emerick B; Schleiniger G; Boman BM
J Math Biol; 2017 Nov; 75(5):1171-1202. PubMed ID: 28271271
[TBL] [Abstract][Full Text] [Related]
31. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells.
Roh H; Green DW; Boswell CB; Pippin JA; Drebin JA
Cancer Res; 2001 Sep; 61(17):6563-8. PubMed ID: 11522655
[TBL] [Abstract][Full Text] [Related]
32. [Roles of Wnt-1, beta-catenin and adenomatous polyposis coli in the differentiation and proliferation of oral squamous cell carcinoma].
Zhang WM; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Nov; 40(6):491-4. PubMed ID: 16329837
[TBL] [Abstract][Full Text] [Related]
33. Adenomatous polyposis coli alteration in digestive endocrine tumours: correlation with nuclear translocation of beta-catenin and chromosomal instability.
Pizzi S; Azzoni C; Tamburini E; Bottarelli L; Campanini N; D'Adda T; Fellegara G; Luong TV; Pasquali C; Rossi G; Delle Fave G; Camisa R; Bordi C; Rindi G
Endocr Relat Cancer; 2008 Dec; 15(4):1013-24. PubMed ID: 18632876
[TBL] [Abstract][Full Text] [Related]
34. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
[TBL] [Abstract][Full Text] [Related]
35. Expression and significance of adenomatous polyposis coli, beta-catenin, E-cadherin and cyclin D1 in esophageal squamous cell carcinoma assessed by tissue microarray.
Peng H; Zhong XY; Liu KP; Li SM
Ai Zheng; 2009 Jan; 28(1):38-41. PubMed ID: 19448414
[TBL] [Abstract][Full Text] [Related]
36. Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells.
Voloshanenko O; Erdmann G; Dubash TD; Augustin I; Metzig M; Moffa G; Hundsrucker C; Kerr G; Sandmann T; Anchang B; Demir K; Boehm C; Leible S; Ball CR; Glimm H; Spang R; Boutros M
Nat Commun; 2013; 4():2610. PubMed ID: 24162018
[TBL] [Abstract][Full Text] [Related]
37. Wnt/beta-catenin signaling in cancer stemness and malignant behavior.
Fodde R; Brabletz T
Curr Opin Cell Biol; 2007 Apr; 19(2):150-8. PubMed ID: 17306971
[TBL] [Abstract][Full Text] [Related]
38. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer.
Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M
Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872
[TBL] [Abstract][Full Text] [Related]
39. Retinol decreases beta-catenin protein levels in retinoic acid-resistant colon cancer cell lines.
Dillard AC; Lane MA
Mol Carcinog; 2007 Apr; 46(4):315-29. PubMed ID: 17219422
[TBL] [Abstract][Full Text] [Related]
40. Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex.
Li VS; Ng SS; Boersema PJ; Low TY; Karthaus WR; Gerlach JP; Mohammed S; Heck AJ; Maurice MM; Mahmoudi T; Clevers H
Cell; 2012 Jun; 149(6):1245-56. PubMed ID: 22682247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
